Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex shareholders announce terms of exchange of Yandex N. V shares

5/13/24 YNDX

Ozon rents logopark for 150,000 sq. m. in Nizhny Novgorod

5/13/24 OZON

M. Video-Eldorado to hold additional issue for 30 million shares

5/13/24 MVID

Rusagro will not pay dividends for 2023

5/13/24 RAGR

Rusagro's net profit decreased by 68% in the first quarter

5/13/24 RAGR

IKS 5 Corporate Center LLC starts transformation into a PJSC

5/8/24 X5

Tinkoff shareholders approve additional share issue for the purchase of Rosbank

5/8/24 ROSB

Tinkoff shareholders approved the additional share issue

5/8/24 T

Board of Directors of Rosseti Center and Volga Region recommended dividends

5/8/24 MRKP

Super Lents will be cleaned by Chinese Pudu CC1 robots

5/8/24 LENT